Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 868 of 6351
-
New monthly shot could simplify schizophrenia treatment
Disease control CompletedThe primary objective of this study is to evaluate the efficacy of TV-44749 in adult participants with schizophrenia. A key secondary objective is to further evaluate the efficacy of TV-44749 based on additional parameters in adult participants with schizophrenia. A secondary o…
Phase 3 • Sponsor: Teva Branded Pharmaceutical Products R&D LLC • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Can cord blood platelets soothe a painful skin condition?
Disease control CompletedVulvar lichen Sclerosus (VLS) is a cutaneous-mucosal dermatosis that causes in the adult female vulvar itching and burning due to scratching abrasions. Dyspareunia is often associated . The areas most affected are the labia minora, the periclitoral area, the navicular dimple, and…
Phase 1/2 • Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Can catching anemia months before joint surgery speed recovery?
Disease control CompletedReducing the occurrence of anemia (low circulating hemoglobin levels) post-surgery has been associated with improved outcome, as it reduces complications and allows for faster return to pre-operative function. Post-operative hemoglobin level is dependent upon its pre-operative va…
Sponsor: Ottawa Hospital Research Institute • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New pill aims to stop High-Risk lymphoma relapse after cell treatment
Disease control Recruiting nowThis phase Ib/II trial studies the side effects and efficacy of maintenance acalabrutinib following cellular therapy in treating patients with large B-cell lymphoma at very high risk of the cancer coming back. Acalabrutinib is a small molecular inhibitor that may interfere with t…
Phase 1/2 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
A simple finger prick could transform hepatitis c care
Diagnosis Recruiting nowThe National Australian HCV Point-of-Care Testing Program will establish an observational cohort to evaluate whether scale-up of finger-stick point-of-care HCV testing increases diagnosis and treatment for HCV infection. Participants will be recruited from settings providing serv…
Sponsor: Kirby Institute • Aim: Diagnosis
Last updated Aug 09, 2026 00:00 UTC
-
New registry to monitor brain ultrasound for Parkinson's tremors
Disease control Recruiting nowThis registry is a prospective, multicenter, international, single arm, observational post-approval registry with follow-up at 3, 6, and 12 months, and annually for 5 years. The proposed registry will enroll 60 subjects and will be conducted at approximately 10 centers worldwide.
Sponsor: InSightec • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Brain scans may forecast language success in children with cochlear implants
Knowledge-focused Recruiting nowThe language outcome of children receiving cochlear implantation to address bilateral sensorineural hearing loss is more variable than that of typical hearing children. The research is focused upon development of neural predictive models based upon brain imaging to forecast langu…
Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Hope for kids with rare kidney disease: drug trial aims to slow damage
Disease control Recruiting nowTo evaluate the pharmacodynamics and safety of tolvaptan in pediatric subjects with ARPKD
Phase 3 • Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Brain scans and blood tests could predict best depression meds
Knowledge-focused Recruiting nowThis is a study that will test a predictive biomarker algorithm based on results from a previous study. The goal of this study is to integrate clinical, imaging, EEG, and molecular data across 8 sites to predict treatment outcome for patients experiencing a major depressive episo…
Phase 4 • Sponsor: Nova Scotia Health Authority • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
Immunotherapy plus chemo and radiation shows promise for bulky lung cancer
Disease control OngoingThis study is a Phase II study to evaluate the clinical efficacy and safety of Toripalimab combined with chemoradiotherapy for large-volume local advanced non-small cell lung cancer
Phase 2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New Sugar-Based PET tracer could spot lung cancer sooner
Diagnosis Recruiting nowThe phase I/II trial assess the safety and efficacy of a new positron emission tomography (PET) test for early diagnosis of lung cancer. This study uses PET and Me-4FDG new glucose tracer (alpha-methyl-4-deoxy-4-\[(18)F\]fluoro-D-glucopyranoside) designed specifically to determin…
Phase 1/2 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Diagnosis
Last updated Jun 27, 2026 07:56 UTC
-
Could supermarket peanuts and milk cure food allergies? new study investigates.
Disease control OngoingFood allergy affects 1 in 30 children, and is the commonest trigger for life-threatening reactions (anaphylaxis) in this age group. It is a major public health issue, with practical implications for industry, education and healthcare systems. Oral immunotherapy (OIT) is an emergi…
Sponsor: University of Southampton • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Online pain coping skills may ease joint pain in breast cancer survivors
Symptom relief OngoingThe main goal of this clinical trial is to test benefits of completing online pain coping skills training program in women who have been diagnosed with stage I-III breast cancer, who have completed their primary cancer treatment, who are taking an AI medication, and who have arth…
Phase 3 • Sponsor: Northwestern University • Aim: Symptom relief
Last updated Jul 10, 2026 00:00 UTC
-
New oral pill TLL018 aims to clear psoriasis plaques in phase 2 trial
Disease control CompletedThis is a Phase 2, multicenter, randomized, double-blinded, parallel dose group, placebo-controlled, dose-ranging study to evaluate the efficacy and safety of 2 doses of TLL018 as therapy in approximately 90 participants with moderate-to-severe PP.
Phase 2 • Sponsor: Hangzhou Highlightll Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Spray chemo shows promise for stomach cancer spread
Disease control Recruiting nowAfter the initial diagnostic laparoscopy the Control group patients undergo 6 courses of polychemotherapy according to the FLOT scheme; the examination is carried out every 3 courses (after the 3rd and the 6th courses) with the control diagnostic laparoscopy after 6 courses of po…
Phase 2 • Sponsor: Nizhny Novgorod Regional Clinical Oncology Center • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New combo therapy aims to prevent dangerous pregnancy condition
Prevention Recruiting nowPreeclampsia is a major cause of maternal and perinatal morbidity and mortality worldwide. Low-dose aspirin started in the first trimester reduces the risk of preeclampsia in high-risk women. Low molecular weight heparin (LMWH) has shown potential benefits in addition to aspirin …
Phase 4 • Sponsor: Alexandra Hospital, Athens, Greece • Aim: Prevention
Last updated Jun 27, 2026 08:13 UTC
-
Can a new pill wipe out hidden myeloma after transplant?
Disease control OngoingSimilar to the paradigm established in other hematologic malignancies that are considered curable, the achievement of MRD(-) status is necessary for long term disease control in MM. The fact that the majority of patients remain MRD (+) after induction therapy and AHCT points to t…
Phase 1/2 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New shot shows promise for major weight loss in obesity and diabetes trial
Disease control CompletedThe study aims to compare and assess the dose response of 3 selected doses of maridebart cafraglutide compared with placebo, on inducing and maintaining weight loss from baseline at Week 52 in participants with overweight or obesity without diabetes mellitus (Cohort A) and in par…
Phase 2 • Sponsor: Amgen • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Experimental chemo combo aims to help kids with rare secondary blood cancers
Disease control OngoingThe purpose of this study is to learn the effects of treatment with an investigational drug, CPX-351 in patients with secondary myeloid neoplasms (SMNs).
Phase 2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Ancient scraping therapy timed to Body's clock may tackle back pain
Symptom relief CompletedBased on the "Cutaneous Region-Meridian-Visceral" axis theory, in this study, we investigated clinical efficacy of the Gua Sha intervention on the Bladder Meridian during the Shen Period (3:00-5:00 p.m.) for lumbar disc herniation (LDH) and its regulatory effect on serum C-reacti…
Sponsor: Guangdong Provincial Hospital of Traditional Chinese Medicine • Aim: Symptom relief
Last updated Aug 12, 2026 00:00 UTC